All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Collegium Pharmaceutical, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Millennium Management LLC, all published on August 9, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Millennium Management LLC
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Collegium Pharmaceutical, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Millennium Management LLC, all published on August 9, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 6 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Millennium Management LLC. Shared-story counts are live from our verified record — not editorial picks.
Collegium Pharmaceutical's earnings beat of $0.20 per share, reaching $1.92 on $199.88M revenue, highlights its commercial success in the abuse-deterrent opioid space, a key sector for the biopharma industry.